Outline of the Project Recommendations on renal function assessment in patients with cardiovascular disease or elevated cardiovascular risk. Russian Societies of Cardiology and Nephrology
About the Authors
V. S. MoiseevRussian Federation
N. A. Mukhin
Russian Federation
Zh. D. Kobalava
Russian Federation
S. V. Villevalde
Russian Federation
M. A. Efremovtseva
Russian Federation
L. V. Kozlovskaya
Russian Federation
Yu. V. Kotovskaya
Russian Federation
V. V. Fomin
Russian Federation
S. A. Shalnova
Russian Federation
References
1. Моисеев B.C., Кобалава Ж.Д. Кардиоренальный синдром (почечный фактор и повышение риска сердечно-сосудистых заболеваний). Клин фармак тер 2002; 11(3): 16-8.
2. Мухин Н.А., Моисеев B.C., Кобалава Ж.Д. и др. Кардиоренальные взаимодействия: клиническое значение и роль в патогенезе заболеваний сердечно-сосудистой системы и почек. Тер архив 2004; 6: 39-46.
3. Мухин Н.А. Снижение скорости клубочковой фильтрации - общепопуляционный маркер неблагоприятного прогноза. Тер архив 2007; 6: 5-10.
4. Sarnak M.J., Levey A.S., Schoolwerth A.C., etal. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension 2003; 42: 1050-65.
5. Vassalotti J.A., Stevens L.A., Levey A.S. Testing for chronic kidney disease: a position statement from the National Kidney Foundation. Am J Kidney Dis 2007; 50(2): 169-80.
6. National Kidney Foundation. K/DOQI Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002; 39(Suppl 1): SI -266.
7. Мое S., Drueke T., Cunningham J., et al. Kidney Disease: Improving Global Outcomes (KDIGO). Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005; 67: 2089-100.
8. European Best Practice Guidelines for Haemodialysis. Part I. Nephrol Dial Transplant 2002; 17(Suppl 7): 7-15.
9. Cockcroft D.W., Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
10. Levey A.S, Bosch J.P., Lewis J.B., et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-70.
11. Stevens AL, Coresh J, Greene T, Levey AS. Assessing Kidney Function -Measured and Estimated Glomerular Filtration Rate. N Engl J Med 2006; 354: 2473-83.
12. Seliger S.L., DeFilippi C. Role of Cystatin С as a Marker of Renal Function and Cardiovascular Risk Medscape 26 Oct 2006. www. medscape.com <http://medscape.com>
13. Dharnidharka V.R., Kwon C., Stevens G. Serum cystatin С is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 2002; 40: 221-6.
14. Смирнов А.В., Добронравов В.А., Каюков И.Г. Проблема хронической болезни почек в современной медицине. Артер гиперт2006; 12(3): 185-93.
15. Шилов Е.Н., Фомин В.В., Швецов М.Ю.Хроническая болезнь почек. Тер архив 2007; 6: 75-8.
16. Томилина Н.А., Бигбов Б.Т Эпидемиология хронической почечной недостаточности и новые подходы к классификации и оценке тяжести хронических прогрессирующих заболевания почек. Тер архив 2005; 6: 87-92.
17. Brosius F.C. III, Hostetter T.H., Kelepouris E. et al. AHA Science advisory on detection of kidney disease in patients with or at increased risk of cardiovascular disease. Circulation 2006; 114: 1083-7.
18. Рекомендации по профилактике, диагностике и лечению артериальной гипертензии. Российские рекомендации (второй пересмотр). Приложение к журналу Кардиоваск тер профил 2004; 4.
19. Mancia G., De Backer G., Dominiczak A., et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25: 1105-87.
20. National Kidney Foundation. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis 2007; 49 (Suppl 2): Sl-180.
21. K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis 2004; 43(5 Suppl 1): Sl-290.
22. Locatelli F., Aljamo P., Barany P., et al. Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure. Nephrol Dial Transplant 2004; 19(Suppl2):iil-47.
23. National Kidney Foundation. K/DOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease. Am J Kidney Dis 2006; 47(Suppl 3): Sl-146.
24. K/DOQI Clinical Practice Guidelines for Managing Dyslipidemias in Chronic Kidney Disease. Am J Kidney Dis 2003;41(Suppl 4):Sl-92.
Review
For citations:
Moiseev V.S., Mukhin N.A., Kobalava Zh.D., Villevalde S.V., Efremovtseva M.A., Kozlovskaya L.V., Kotovskaya Yu.V., Fomin V.V., Shalnova S.A. Outline of the Project Recommendations on renal function assessment in patients with cardiovascular disease or elevated cardiovascular risk. Russian Societies of Cardiology and Nephrology. Cardiovascular Therapy and Prevention. 2008;7(4):8-20. (In Russ.)